Greg Gilman is a General Partner at Science. He is also the Co-Founder and Executive Chairman of RxVantage.
What Greg can write
Writes checks ofNot reported
Comes in atPre-seed, Seed, Series ACan lead the round
Ownership target7-10%At first check
Best routeA warm introAsk a founder in their portfolio.
Career
- RxVantage · Co-Founder and Executive Chairman
- Science · General PartnerNow
Companies founded
RxVantage
Investments named in public bios
DocStocTsavoUserplaneMaker StudiosPlutoTVScopelyZipRecruiterMammoth MediaRealBlocksProtegoPray
Focus
Financial technologiescryptography and distributed systemshealthcare innovation
Also at Science
Partners like Greg
At firms with a similar stage, sector and check size.
Alert me when Science is active
One email when Greg's firm raises a fund, adds a partner or shows new activity.
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckQuestions
Who is Greg Gilman?
Greg Gilman is a General Partner at Science. He is also the Co-Founder and Executive Chairman of RxVantage.
How much does Greg Gilman invest?
Science has not reported a check size. It invests at pre-seed, seed, series a.
How do I pitch Greg Gilman?
A warm intro from a founder Science backed works best.
What did Greg Gilman do before Science?
Co-Founder and Executive Chairman at RxVantage.
Last updated 2026-10-15. Is this you? Ask for a correction.